Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents. | Mol Oncol | 2024 | 37854019 | PubTator, text mining | PubMed |
| SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia. | Haematologica | 2024 | 37608777 | PubTator, text mining | PubMed |
| NK cell-based tumor immunotherapy. | Bioact Mater | 2024 | 37601277 | PubTator, text mining | PubMed |
| CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer. | Biomol Biomed | 2024 | 37597212 | PubTator, text mining | PubMed |
| EBV-microRNAs as Potential Biomarkers in EBV-related Fever: A Narrative Review. | Curr Mol Med | 2024 | 36411555 | PubTator, text mining | PubMed |
| Gamma/delta T cells as cellular vehicles for anti-tumor immunity. | Front Immunol | 2023 | 38274800 | PubTator, text mining | PubMed |
| Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors. | Front Pharmacol | 2023 | 38264532 | PubTator, text mining | PubMed |
| Unlocking antitumor immunity with adenosine receptor blockers. | Cancer Drug Resist | 2023 | 38263981 | PubTator, text mining | PubMed |
| Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis. | Pharmaceutics | 2023 | 38258042 | PubTator, text mining | PubMed |
| Immunomodulatory effects of exercise in cancer prevention and adjuvant therapy: a narrative review. | Front Physiol | 2023 | 38239881 | PubTator, text mining | PubMed |
| Current status and future perspective of natural killer cell therapy for cancer. | Med Rev (2021) | 2023 | 38235405 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances. | Cancers (Basel) | 2023 | 38201469 | PubTator, text mining | PubMed |
| Immunological Aspects of Infertility-The Role of KIR Receptors and HLA-C Antigen. | Cells | 2023 | 38201263 | PubTator, text mining | PubMed |
| Current status and future challenges of CAR-T cell therapy for osteosarcoma. | Front Immunol | 2023 | 38187386 | PubTator, text mining | PubMed |
| The HLA-B*57:01 allele corresponds to a very large MHC haploblock likely explaining its massive effect for HIV-1 elite control. | Front Immunol | 2023 | 38146367 | PubTator, text mining | PubMed |
| High-resolution DNA methylation screening of the major histocompatibility complex in multiple sclerosis. | Front Neurol | 2023 | 38145128 | PubTator, text mining | PubMed |
| Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 38139416 | PubTator, text mining | PubMed |
| The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy. | Int J Mol Sci | 2023 | 38139373 | PubTator, text mining | PubMed |
| The Role of γδ T-Lymphocytes in Glioblastoma: Current Trends and Future Directions. | Cancers (Basel) | 2023 | 38136330 | PubTator, text mining | PubMed |
| γδ T cells as immunotherapy for malaria: balancing challenges and opportunities. | Front Immunol | 2023 | 38124746 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=10